Amador Bioscience

company

About

Amador Bioscience provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$60M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2018
Number Of Employee
101 - 250
Operating Status
Active

Amador Bioscience, a contract research organization (CRO) that provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$60M
Amador Bioscience has raised a total of $60M in funding over 2 rounds. Their latest funding was raised on Dec 30, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 30, 2021 Series B $60M 1 Detail
Sep 28, 2021 Series B 1 Sequoia Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Amador Bioscience is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Series B